18 Aug 2026, 10:12 PM 2 min readentertainmentdeveloping
FDA Issues Notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff
Regulatory Action:
The Maharashtra Food and Drug Administration has issued formal show-cause notices to prominent Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their appearance in promotional advertisements for branded cardamom products that allegedly function as surrogate marketing for restricted pan masala brands.
Endorsement Scrutiny:
The regulatory intervention highlights growing official scrutiny over celebrity brand endorsements and surrogate advertising practices in India. Consumer welfare advocates have long criticized prominent personalities for lending their star power to items associated with tobacco or restricted substances through brand-extension strategies.
Industry Impact:
The actors face heightened compliance pressures and potential legal repercussions under food safety and standard regulations. Film industry stakeholders are closely monitoring the case as it sets a major precedent for celebrity liability in commercial advertising across the country.
Pulse Intelligence
Context & ImpactContext & Background
- Consumer advocacy groups have repeatedly petitioned regulatory bodies to crack down on surrogate advertising by top-tier film stars.
- State and national food safety authorities have ramped up inspections on tobacco-adjacent product marketing and statutory warning compliance.
Key Consequences
- The targeted actors must provide formal explanations to the Maharashtra FDA within the stipulated legal timeframe.
- Advertisers and brands may alter their endorsement strategies to avoid direct regulatory penalties and public scrutiny.
- Celebrities could face stricter self-regulation regarding commercial brand deals and surrogate product promotions.
Market & Economic Impact
No direct market impact.
The Indus Pulse is committed to accuracy and transparency.

